-Dendreon to Hold Conference Call on Tuesday, August 12, 2008 at 4:30 PM ET-
A recorded rebroadcast will be available for interested parties unable toparticipate in the live conference call by dialing 1-888-203-1112 or+1-719-457-0820 for international callers; the conference ID number is5805154. The replay will be available from 7:30 pm ET on Tuesday, August 12until 11:59 pm ET on Thursday, August 14. In addition the webcast will bearchived for on-demand listening for 30 days at http://www.dendreon.com.
Dendreon Corporation is a biotechnology company whose mission is to targetcancer and transform lives through the discovery, development andcommercialization of novel therapeutics. The Company applies its expertise inantigen identification, engineering and cell processing to produce activecellular immunotherapy product candidates designed to stimulate an immuneresponse. Dendreon is also developing an orally-available small moleculecalled Trp-p8 that could be applicable to multiple types of cancer as well asbenign prostatic hyperplasia. The Company has its headquarters in Seattle,Washington and is traded on the Nasdaq Global Market under the symbol DNDN.For more information about the Company and its programs, visithttp://www.dendreon.com.Time: 4:30 PM ET /1:30 PM PT Date: August 12, 2008 Dial-in: 1-877-545-1407 (domestic) or +1-719-325-4904 (international) Webcast: http://www.dendreon.com (homepage and investor relations section)
SOURCE Dendreon Corporation
You May Also Like